Company / Depreciation & Amortization
United Therapeutics Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$85.6M
FY2025
5-year range
$49.9M / $85.6M
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
#23 of 168
Health Care
What the data says
United Therapeutics's depreciation & amortization of $86M is higher than 86% of companies in the Health Care sector (FY2025). Depreciation & Amortization has increased for 4 consecutive years, from $50M in FY2021 to $86M in FY2025.
Based on SEC 10-K filings.
$86M in FY2025 with a 5-year CAGR of +11.4%. Top quartile in the Health Care sector.
Increased from $53M to $86M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +18.6%
- 5-Year CAGR
- +11.4%
- 10-Year CAGR
- -
Sector benchmark
-59.8% below sector average
Key checks
Key Insights
- United Therapeutics's depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +11.4%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 18.1% year-over-year.
- Ranks #23 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $85.6M | +18.1% |
| FY2024 | $72.5M | +36.3% |
| FY2023 | $53.2M | +3.7% |
| FY2022 | $51.3M | +2.8% |
| FY2021 | $49.9M | +0.0% |
| FY2020 | $49.9M | +8.7% |
| FY2019 | $45.9M | +27.9% |
| FY2018 | $35.9M | +9.1% |
| FY2017 | $32.9M | +4.1% |
| FY2016 | $31.6M | -4.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026